Former FDA official talks about significance of SCOTUS decision on Mifepristone

The Supreme Court is expected to issue a ruling on Friday about whether the sale of Mifespristone, a drug used for abortion, will continue amid a legal challenge. LiveNOW from FOX's Josh Breslow was joined by Dr. Joshua Sharfstein, a former principal deputy commissioner for the FDA, to discuss the significance of the ruling.